1086261

Gregory Pharmaceutical Holdings Inc. dba UPM Pharmaceuticals Inc. — FEI 1000208638

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 12, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bristol, TN (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
200821 CFR 211.186(a)Written procedures followed
202721 CFR 211.192Investigations of discrepancies, failures